Where can I buy Midostaurin? Formal drug purchasing channels and precautions

Midostaurin As an importantFLT3 inhibitor, it is a key targeted drug in the treatment of leukemia in recent years, especially FLT3 mutation-positive acute myeloid leukemia (AML). The brand name of its original drug is Rydapt, which was developed by the pharmaceutical company Novartis and marketed in many countries. It is currently mainly sold in Europe, the United States, India, Southeast Asia, Hong Kong and other regions. Unfortunately, as of now, the original drug Midostaurin has not been officially approved for marketing in mainland China, so it cannot be obtained through domestic hospitals or pharmacies, and it has not been included in the Chinese medical insurance directory. This means that domestic patients who seek midostaurin treatment must obtain it through overseas drug purchase channels, and all costs must be borne at their own expense.

From the perspective of legal drug purchase, if patients need to obtain midostaurin, it is recommended that they give priority to formal channels. The first way is to purchase it through overseas hospitals or pharmacies. Currently, the original version of Rydapt can be purchased in the European market (and pharmacies in Hong Kong). These drugs are usually European specifications, 25mg*112 pills per box, and the price ranges from RMB 50,000 to RMB 70,000. The Hong Kong version of the original drug is also available in some large stores in Hong Kong. It can be issued in pharmacies of large hospitals and can be applied for by mainland patients with prescriptions through Hong Kong and Macao. The second is to obtain it through overseas medical service platforms or international drug purchasing agencies, provided that patients have a medical order or prescription. Patients must pay attention to identify whether the platform is legal and compliant to avoid buying fake drugs or unregulated generic drugs.

In addition to the original drug, some countries such as India and Bangladesh have also launched generic versions of midostaurin. The specifications of the generic version of midostaurin produced by India's BDR Pharmaceutical Company are the same as those of the original drug. The price is about 3,000-5,000 yuan per box. The ingredients of the drug are basically the same as Rydapt, and it is regarded by some patients as a cost-effective alternative.

Reference materials:https://medlineplus.gov/druginfo/meds/a617033.html